Botox could ease depression in addition to wrinkles, study finds

Botox injections may do more than erase the signs of age, or prevent you from feeling painful migraines — they may alleviate depression as well, a new study confirms.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

If I come forward with my mental illness, will it shame my family? If I go to a psychiatrist, does it mean I don’t have enough faith to heal myself? While these questions might seem odd to some people, these are very real worries for many in the Asian and Christian communities. In today’s episode, Dr. Esther Park, who is both Korean and Christian, explains the mental health stigma she has seen in both of these circles. Dr. Park helps clarify these issues and encourages people in these groups to understand the importance of seeking professional help. We want to hear from you — Please fill out our listener...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Disorders General Interview Mental Health and Wellness Podcast Spirituality Stigma The Psych Central Show Source Type: blogs
Authors: Bao X, Liu H, Liu HY, Long Y, Tan JW, Zhu ZM Abstract OBJECTIVE: To study the effect of intermittent hypoxia training (IHT) for migraine. DESIGN: A single-blind, randomized controlled trial. All participants were recruited from a rehabilitation department in an acute university-affiliated hospital. METHODS: Participants with migraines were randomly assigned to two groups (IHT group and control group). The Migraine Disability Assessment (MIDAS), Visual Analog Scale (VAS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Vascular endothelial growth factor (VEGF), calcitonin gene related...
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
Conclusion: This systematic review and NMA will provide comprehensive and convincing evidence regarding analgesic medication for pain after ambulatory surgery. Trial registration number: CRD42018100000.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
By HANS DUVEFELT, MD Now that we are seeing patients via telemedicine or even getting reimbursed for handling their issues over the phone, our existing healthcare institutions are more and more starting to look like shopping malls.  They were once traffic magnets, so large that they created new developments far away from where people lived or worked and big and complex enough that going there became an all day affair for many people.  What this pandemic has brought us is a shift in our view of where you have to be in order to get things done. If you can earn your wage remotely and still buy things online...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Medical Practice Source Type: blogs
Abstract BACKGROUND AND OBJECTIVES: The association between migraine, depression, and anxiety has been established, but the impact of these psychiatric comorbidities on functional impairment in people with migraine has been under-investigated. The purpose of this cross-sectional observational study was to investigate the relationship between anxiety and depression symptoms on migraine-related disability, pain interference, work interference, and career success in a cohort of patients with migraine. METHODS: This analysis included 567 migraine patients who had been enrolled into the American Registry for Migra...
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research
MONDAY, Aug. 3, 2020 -- Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression, according to a study published online July 30 in Scientific...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation orbehavior.1 SPRAVATO® is the first and only approved medicine that has been shown to reduce depressive symptoms within 24 hours,1 providing a new option for significant symptom relief until a longer-ter...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
A 58-year-old woman experienced 4 months of headache, fatigue, and depression, as well as 1 week of confusion and hallucinations. 18F-FDG PET/CT showed numerous hypermetabolic lesions in the pituitary gland and stalk, dura mater, glossopharyngeal nerve, and cauda equina, as well as in cervical and mediastinal lymph nodes. Surgical biopsy of the mediastinal lymph node confirmed the diagnosis of sarcoidosis. The follow-up 18F-FDG PET/CT, performed at the eighth month after the treatment of glucocorticoids and immunosuppressive agents, demonstrated complete remission of the previous hypermetabolic lesions.
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Interesting Images Source Type: research
THURSDAY, July 30, 2020 -- Botox injections used to fight wrinkles and prevent migraines may also help relieve depression, a new study suggests. Patients who received Botox injections for any of six conditions reported suffering depression 40% to...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
CONCLUSIONS: Vigabatrin may significantly reduce seizure frequency in people with drug-resistant focal epilepsy. The results largely apply to adults and should not be extrapolated to children under 10 years old. Short-term follow-up of participants showed that some adverse effects were associated with its use. Analysis of longer-term observational studies elsewhere, however, has demonstrated that vigabatrin use can lead to the development of visual field defects. PMID: 32730657 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Tags: Cochrane Database Syst Rev Source Type: research
More News: Botox | Depression | Headache | Health | Migraine | Study